Effect of racemic MEPHOBARBITAL (cas 115-38-8) and d-MEPHOBARBITAL (cas 115-38-8) on hepatic microsomal enzyme induction in rat and monkey
-
Add time:08/26/2019 Source:sciencedirect.com
A standardized procedure for the routine measurement of hepatic mixed function oxidases including aminopyrine N-demethylase, p-nitroanisole O-demethylase, aniline hydroxylase, and azoreductase was used to examine enzyme alteration due to chronic drug administration. Oral treatment of monkeys or rats with either racemic MEPHOBARBITAL (cas 115-38-8) or d-mephobarbital significantly increased liver weights and hepatic microsomal enzyme activities. Racemic mephobarbital-treated rats demonstrated higher hepatic enzyme activities compared to d-mephobarbital-treated rats. No differences were noted in the degree of induction of enzyme activities due to either isomer in the monkey.
We also recommend Trading Suppliers and Manufacturers of MEPHOBARBITAL (cas 115-38-8). Pls Click Website Link as below: cas 115-38-8 suppliers
Prev:Research ArticlesApplication of Magnesium Silicate Adsorption Chromatography to the Determination of MEPHOBARBITAL (cas 115-38-8) and Diphenylhydantoin in Tablets
Next:Synthesis of N-β-d-glucopyranosyl derivatives of barbital, phenobarbital, metharbital, and MEPHOBARBITAL (cas 115-38-8)☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis of N-β-d-glucopyranosyl derivatives of barbital, phenobarbital, metharbital, and MEPHOBARBITAL (cas 115-38-8)☆08/27/2019
- Research ArticlesApplication of Magnesium Silicate Adsorption Chromatography to the Determination of MEPHOBARBITAL (cas 115-38-8) and Diphenylhydantoin in Tablets08/25/2019
- SNP CommunicationA Novel Single Nucleotide Polymorphism (SNP) of the CYP2C19 Gene in a Japanese Subject with Lowered Capacity of MEPHOBARBITAL (cas 115-38-8) 4′-Hydroxylation08/24/2019
- Synthesis of N-β-d-glucopyranosyluronate derivatives of barbital, phenobarbital, metharbital, and MEPHOBARBITAL (cas 115-38-8)08/23/2019
- The antiepileptic drug MEPHOBARBITAL (cas 115-38-8) is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood–brain barrier: A positron emission tomography study08/22/2019